- Home
- AGIO vs NGD Comparison
AGIO vs NGD Comparison
Compare AGIO & NGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- NGD
- Stock Information
- Founded
- AGIO 2007
- NGD N/A
- Country
- AGIO United States
- NGD Canada
- Employees
- AGIO N/A
- NGD N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- NGD
- Sector
- AGIO Health Care
- NGD
- Exchange
- AGIO Nasdaq
- NGD Nasdaq
- Market Cap
- AGIO 2.4B
- NGD 2.4B
- IPO Year
- AGIO 2013
- NGD 2004
- Fundamental
- Price
- AGIO $41.33
- NGD $2.80
- Analyst Decision
- AGIO Hold
- NGD Buy
- Analyst Count
- AGIO 5
- NGD 4
- Target Price
- AGIO $52.50
- NGD $3.04
- AVG Volume (30 Days)
- AGIO 585.1K
- NGD 11.5M
- Earning Date
- AGIO 10-31-2024
- NGD 10-29-2024
- Dividend Yield
- AGIO N/A
- NGD N/A
- EPS Growth
- AGIO N/A
- NGD N/A
- EPS
- AGIO N/A
- NGD N/A
- Revenue
- AGIO $31,306,000.00
- NGD $810,800,000.00
- Revenue This Year
- AGIO $44.80
- NGD $24.11
- Revenue Next Year
- AGIO $174.95
- NGD $19.04
- P/E Ratio
- AGIO N/A
- NGD N/A
- Revenue Growth
- AGIO 55.39
- NGD 15.83
- 52 Week Low
- AGIO $19.80
- NGD $1.00
- 52 Week High
- AGIO $53.29
- NGD $3.25
- Technical
- Relative Strength Index (RSI)
- AGIO 37.77
- NGD 48.42
- Support Level
- AGIO $40.37
- NGD $2.85
- Resistance Level
- AGIO $46.24
- NGD $3.00
- Average True Range (ATR)
- AGIO 2.35
- NGD 0.11
- MACD
- AGIO -0.66
- NGD -0.05
- Stochastic Oscillator
- AGIO 7.39
- NGD 2.17
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.